Literature DB >> 26628456

Inferior petrosal sinus route microcatheterization study and embolization for primary orbital varix.

Vivek Singh1, R V Phadke2, Alok Udiya1, Gurucharan S Shetty1, Kumudini Sharma3, Vikas Kanaujia3.   

Abstract

PURPOSE: Primary orbital varix is a rare lesion but difficult to treat. Our main aim was to demonstrate the varices and their central venous communication and to explore the feasibility of embolization of these lesions.
METHOD: In four patients with clinical suspicion of varix, in whom MRI showed retro-global vascular channels, microcatheter digital subtraction angiography (DSA) of the varices was performed using femoral venous access. Embolization was carried out in two patients.
RESULTS: In all four patients orbital varices could be accessed with a microcatheter through inferior petrosal sinus and ophthalmic vein (superior or inferior) route. Microcatheter angiography showed opacification of varices and demonstrated their central venous communication. Two patients were treated with coil embolization. Complete resolution of symptoms was seen in one patient and partial relief in the other.
CONCLUSION: The study presents microcatheterization of orbital varices via the inferior petrosal sinus-cavernous sinus-ophthalmic vein route with injections into distal ophthalmic veins for demonstration of these variceal sacs and their central venous connection. Coiling to disconnect the venous communication should be the primary goal of embolization.
© The Author(s) 2015.

Entities:  

Keywords:  Orbital varix; embolization; neuro-ophthalmology

Mesh:

Year:  2015        PMID: 26628456      PMCID: PMC4757384          DOI: 10.1177/1591019915617318

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  15 in total

1.  Surgical treatment of orbital varices.

Authors:  G X Song; W F Tian; D F Qiang; J I Liu
Journal:  Chin Med J (Engl)       Date:  1979-10       Impact factor: 2.628

2.  Embolisation of Orbital Varix via the Superficial Temporal Vein.

Authors:  N Mavilio; A Pau; R Pisani; A Casasco; M Rosa
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

Review 3.  Orbital vascular anatomy.

Authors:  S S Hayreh
Journal:  Eye (Lond)       Date:  2006-10       Impact factor: 3.775

4.  Spiral CT of an orbital venous malformation.

Authors:  P A Rubin; J R Bilyk; I M Dunya; A L Weber
Journal:  AJNR Am J Neuroradiol       Date:  1995 Jun-Jul       Impact factor: 3.825

5.  Embolization of an orbital varix after surgical exposure.

Authors:  A Weill; C Cognard; L Castaings; G Robert; J Moret
Journal:  AJNR Am J Neuroradiol       Date:  1998-05       Impact factor: 3.825

6.  Orbital venous anomalies demonstrated by spiral computed tomography.

Authors:  P A Rubin; H D Remulla
Journal:  Ophthalmology       Date:  1997-09       Impact factor: 12.079

7.  Embolisation of orbital varix.

Authors:  A Takechi; T Uozumi; K Kiya; T Yano; M Sumida; S Yoshikawa; B Pant
Journal:  Neuroradiology       Date:  1994-08       Impact factor: 2.804

8.  Distensible venous malformations of the orbit: clinical and hemodynamic features and a new technique of management.

Authors:  B Lacey; J Rootman; T R Marotta
Journal:  Ophthalmology       Date:  1999-06       Impact factor: 12.079

Review 9.  Vascular lesions of the orbit: more than meets the eye.

Authors:  Wendy R K Smoker; Lindell R Gentry; Norbert K Yee; Deborah L Reede; Jeffrey A Nerad
Journal:  Radiographics       Date:  2008 Jan-Feb       Impact factor: 5.333

Review 10.  Nontraumatic orbital conditions: diagnosis with CT and MR imaging in the emergent setting.

Authors:  Christina A LeBedis; Osamu Sakai
Journal:  Radiographics       Date:  2008-10       Impact factor: 5.333

View more
  1 in total

1.  Unusual ectopic ACTH syndrome in a patient with orbital neuroendocrine tumor, resulted false-positive outcome of BIPSS:a case report.

Authors:  Huiwen Tan; Dawei Chen; Yerong Yu; Kai Yu; Weiming He; Bowen Cai; Su Jiang; Ying Tang; Nanwei Tong; Zhenmei An
Journal:  BMC Endocr Disord       Date:  2020-07-31       Impact factor: 2.763

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.